spacer
home > epc > media info
MEDIA INFORMATION

Click here to view the EPC media pack

EPC offers an industry-leading platform, which includes:
  • An international readership of pharma and biotech decision-makers, plus full-service and speciality CROs, in print and online
  • Strong, opinion-led editorial comment and analysis
  • Affiliation with international trade events and conferences
  • An impressive record of long-term advertising partnerships and a loyal affiliate network
  • Multimedia presence to reach a global audience
Each edition of EPC runs a number of expert, discussion-based features on the latest contract research and outsourcing moves. Topics regularly covered include:
  • CRO market analysis
  • Biopharmaceutical development
  • Non-clinical pharmacology/toxicology
  • Laboratory services (bioanalytical labs, central labs)
  • Biosimilars development
  • Biomarkers and assay development
  • Data management
  • Biostatistics
  • Pharmacovigilance
  • Chemistry, manufacturing, controls
  • Strategic and regulatory planning
  • Pricing and market access
  • Contract planning
  • Outsourcing models (eg full service, functional service provider)
  • Supplier selection
  • Managing supplier relationships
  • Procurement practices
  • Technical innovation
  • Business process management
  • CRO performance metrics
spacer



Published quarterly in
February, May,
August and November
 
Industry Events

ISPPP_2017

19-21 July 2017, Philadelphia, PA, USA

Mark your calendar to attend the premier meeting on state-of-the-art separation, analysis, and characterization methods, much of which is based on HPLC/UHPLC/Mass Spectrometry.
More info >>

 
News and Press Releases

Aptar Pharma’s Electronic Lockout Device Approved by EMA

Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approval by the EMA of the first integrated electronic nasal lockout device following a multi-year development with Takeda Pharmaceuticals International AG.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement